D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
ResMed
RMD
$40.9B
| $41.9M | 0.04% |
191,941
+30,990
| +19% | +$6.77M |
|
277
PROG Holdings
PRG
$1.38B
| $41.9M | 0.04% |
1,303,875
-159,817
| -11% | -$5.13M |
|
278
British American Tobacco
BTI
$123B
| $41.7M | 0.04% |
1,254,853
+879,126
| +234% | +$29.2M |
|
279
Revvity
RVTY
$9.87B
| $41.3M | 0.04% |
348,055
+42,886
| +14% | +$5.09M |
|
|
EVBG
280
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $41.3M | 0.04% |
1,535,106
-147,904
| -9% | -$3.98M |
|
281
Teva Pharmaceuticals
TEVA
$22.6B
| $41.1M | 0.04% |
5,455,730
+4,039,979
| +285% | +$30.4M |
|
282
Frontline
FRO
$5.01B
| $40.8M | 0.04% |
2,807,696
-806,955
| -22% | -$11.7M |
|
283
Vaxcyte
PCVX
$4.25B
| $40.6M | 0.04% |
812,912
+18,005
| +2% | +$899K |
|
284
Zillow
ZG
$20.3B
| $40.6M | 0.04% |
825,041
-119,216
| -13% | -$5.87M |
|
285
Yelp
YELP
$2B
| $40.5M | 0.04% |
1,113,377
-66,701
| -6% | -$2.43M |
|
286
Trip.com Group
TCOM
$47.3B
| $40.5M | 0.04% |
1,157,052
+1,008,634
| +680% | +$35.3M |
|
287
Dominion Energy
D
$50.2B
| $40.4M | 0.04% |
780,586
-590,077
| -43% | -$30.6M |
|
288
Chegg
CHGG
$168M
| $40.4M | 0.04% |
4,544,346
+1,086,425
| +31% | +$9.65M |
|
289
Trimble
TRMB
$19.1B
| $40.2M | 0.04% |
759,549
+41,839
| +6% | +$2.21M |
|
290
PNC Financial Services
PNC
$78.9B
| $40M | 0.04% |
317,367
-373,548
| -54% | -$47M |
|
291
Kimberly-Clark
KMB
$43.5B
| $39.9M | 0.04% |
289,058
+95,665
| +49% | +$13.2M |
|
292
Rambus
RMBS
$8.02B
| $39.8M | 0.04% |
619,792
-450,807
| -42% | -$28.9M |
|
293
Wells Fargo
WFC
$259B
| $39.6M | 0.04% |
927,307
-3,594,051
| -79% | -$153M |
|
294
Citizens Financial Group
CFG
$22.3B
| $39.4M | 0.04% |
+1,509,615
| New | +$39.4M |
|
295
Republic Services
RSG
$71.5B
| $39.4M | 0.04% |
256,998
+20,597
| +9% | +$3.15M |
|
|
PXD
296
DELISTED
Pioneer Natural Resource Co.
PXD
| $39.4M | 0.04% |
189,941
-146,481
| -44% | -$30.3M |
|
297
Salesforce
CRM
$240B
| $39.3M | 0.04% |
186,221
-185,230
| -50% | -$39.1M |
|
298
Nutanix
NTNX
$20.3B
| $39.2M | 0.04% |
1,398,911
+87,180
| +7% | +$2.45M |
|
299
Dynatrace
DT
$15.3B
| $39.1M | 0.04% |
760,555
+315,140
| +71% | +$16.2M |
|
300
TG Therapeutics
TGTX
$5.08B
| $39.1M | 0.04% |
1,575,471
+741,694
| +89% | +$18.4M |
|